[
  {
    "ts": null,
    "headline": "Jim Cramer Applauds Abbott Laboratories (ABT): “A Tour de Force Quarter – Robert Ford Is Keeping the Miles White Legacy Alive”",
    "summary": "We recently published a list of Jim Cramer Defended American Superiority and Discussed These 13 Stocks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discussed. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer highlighted the often-overlooked role of […]",
    "url": "https://finnhub.io/api/news?id=30476f5dfd97028afc8fff1bd3c804362a4519069eec93d8115a080aff71a85e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745078815,
      "headline": "Jim Cramer Applauds Abbott Laboratories (ABT): “A Tour de Force Quarter – Robert Ford Is Keeping the Miles White Legacy Alive”",
      "id": 134012981,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "We recently published a list of Jim Cramer Defended American Superiority and Discussed These 13 Stocks. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discussed. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer highlighted the often-overlooked role of […]",
      "url": "https://finnhub.io/api/news?id=30476f5dfd97028afc8fff1bd3c804362a4519069eec93d8115a080aff71a85e"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Labs' Rally Is Well Deserved - Fade The Rally For Now",
    "summary": "Abbott's growth potential with GLP-1 tailwinds, robust FCF, and dividend growth. Read more on how ABT navigates tariffs while staying poised to outperform.",
    "url": "https://finnhub.io/api/news?id=b3650ecc023d40291a74f0efd7d5c9538fa32f1163413b7188b01341e50fc666",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745056440,
      "headline": "Abbott Labs' Rally Is Well Deserved - Fade The Rally For Now",
      "id": 133971923,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1249102037/image_1249102037.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "Abbott's growth potential with GLP-1 tailwinds, robust FCF, and dividend growth. Read more on how ABT navigates tariffs while staying poised to outperform.",
      "url": "https://finnhub.io/api/news?id=b3650ecc023d40291a74f0efd7d5c9538fa32f1163413b7188b01341e50fc666"
    }
  }
]